2021 |
Marshall, H. S., Andraweera, P. H., Wang, B., McMillan, M., Koehler, A. P., Lally, N., . . . Flood, L. (2021). Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol. Human Vaccines and Immunotherapeutics, 1-5. DOI |
2021 |
Strachan, R., Homaira, N., Beggs, S., Bhuiyan, M. U., Gilbert, G. L., Lambert, S. B., . . . Jaffé, A. (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax. DOI |
2020 |
Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2020). Spatial, temporal, and occupational risks of Q fever infection in South Australia, 2007-2017.. Journal of infection and public health, 13(4), 544-551. DOI Scopus2 WoS2 |
2020 |
Clarke, M., Liew, Y., Mathew, S., & Marshall, H. (2020). Clinical Severity of Gastroenteritis in Children Hospitalized With Rotavirus Infection Before and Post Introduction of a National Rotavirus Vaccination Program in Australia. The Pediatric infectious disease journal, 39(9), e289-e290. DOI |
2020 |
Marshall, H., Koehler, A., Wang, B., A'Houre, M., Gold, M., Quinn, H., . . . Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922. DOI |
2020 |
Aye, A. M. M., Bai, X., Borrow, R., Bory, S., Carlos, J., Caugant, D. A., . . . Zhu, B. (2020). Meningococcal disease surveillance in the Asia–Pacific region (2020): The global meningococcal initiative. Journal of Infection, 81(5), 698-711. DOI Scopus1 WoS1 |
2020 |
Madhi, S., Polack, F., Piedra, P., Munoz, F., Trenholme, A., Simões, E., . . . Fries, L. (2020). Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. The New England journal of medicine, 383(5), 426-439. DOI Scopus14 WoS14 Europe PMC5 |
2020 |
Marshall, H., & Wood, N. (2020). The potential for improved protection against pertussis. The Lancet Infectious Diseases, 20(11), 1220-1222. DOI |
2020 |
Marshall, H. S., & Maiden, M. C. J. (2020). The impact of a meningococcal protein-based serogroup B vaccine on serogroup W invasive disease in children.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. DOI |
2020 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Dekker, G. A., & Marshall, H. S. (2020). Safety and protective effects of maternal influenza vaccination on pregnancy and birth outcomes: A prospective cohort study. EClinicalMedicine, 26, 9 pages. DOI Scopus1 |
2020 |
Rahaman, M., Milazzo, A., Marshall, H., Chaber, A. -L., & Bi, P. (2020). Q fever vaccination: Australian animal science and veterinary students’ One Health perspectives on Q fever prevention. Human Vaccines and Immunotherapeutics, 8 pages. DOI |
2020 |
Carlson, S. J., Quinn, H. E., Blyth, C. C., Cheng, A., Clark, J., Francis, J. R., . . . Leask, J. (2020). Barriers to influenza vaccination of children hospitalised for acute respiratory illness: a cross-sectional survey. Journal of Paediatrics and Child Health, OnlinePubl, 1-10. DOI |
2020 |
Tuckerman, J. L., Kaufman, J., Danchin, M., & Marshall, H. S. (2020). Influenza vaccination: a qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions. Vaccine, 38(49), 7806-7814. DOI |
2020 |
McMillan, M., Chandrakumar, A., Wang, H. L. R., Clarke, M., Sullivan, T. R., Andrews, R. M., . . . Marshall, H. S. (2020). Effectiveness of meningococcal vaccines at reducing invasive meningococcal disease and pharyngeal Neisseria meningitidis carriage: A systematic review and meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. DOI |
2020 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L. C., Verburg, P. E., Dekker, G., & Marshall, H. S. (2020). Safety of maternal pertussis vaccination on pregnancy and birth outcomes: a prospective cohort study. Vaccine, 39(2), 1-8. DOI |
2020 |
Britton, P. N., Dale, R. C., Blyth, C. C., Clark, J. E., Crawford, N., Marshall, H., . . . Jones, C. A. (2020). Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clinical Infectious Diseases, 70(12), 2517-2526. DOI Scopus4 WoS6 |
2020 |
Marshall, H. S., Lally, N., Flood, L., & Phillips, P. (2020). First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Medical Journal of Australia, 212(2), 89-93. DOI Scopus3 WoS3 |
2020 |
Marshall, H. S., McMillan, M., Koehler, A. P., Lawrence, A., Sullivan, T. R., MacLennan, J. M., . . . Richmond, P. (2020). Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. The New England Journal of Medicine, 382(4), 318-327. DOI Scopus33 WoS31 Europe PMC7 |
2020 |
Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2020). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2020(1). DOI |
2020 |
Mohammed, H., Roberts, C. T., Grzeskowiak, L. E., Giles, L., Leemaqz, S., Dalton, J., . . . Marshall, H. S. (2020). Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study.. Vaccine, 38(17), 3358-3368. DOI Scopus1 WoS1 |
2020 |
Thielemans, E., Oliver, J., McMinn, A., Baker, C., Britton, P. N., Clark, J., . . . Steer, A. C. (2020). Clinical description and outcomes of Australian children with invasive group a streptococcal disease. Pediatric Infectious Disease Journal, 39(5), 379-384. DOI Scopus1 Europe PMC1 |
2020 |
Blyth, C. C., Cheng, A. C., Crawford, N. W., Clark, J. E., Buttery, J. P., Marshall, H. S., . . . Macartney, K. K. (2020). The impact of new universal child influenza programs in Australia: vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine, 38(13), 2779-2787. DOI Scopus3 WoS3 |
2020 |
Menzies, R., Heron, L., Lampard, J., McMillan, M., Joseph, T., Chan, J., . . . Marshall, H. (2020). A randomised controlled trial of SMS messaging and calendar reminders to improve vaccination timeliness in infants. Vaccine, 38(15), 3137-3142. DOI Scopus3 WoS2 Europe PMC1 |
2020 |
Pearce, J., Peters, M., May, N., Marshall, H., Hein, C., & Grantham, H. (2020). Care of the patient with invasive meningococcal disease by prehospital emergency medical service clinicians: a scoping review. BMJ Open, 10(2), e033447-1-e033447-11. DOI |
2020 |
Wnukowski-Mtonga, P., Jayasinghe, S., Chiu, C., Macartney, K., Brotherton, J., Donovan, B., . . . Marshall, H. (2020). Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable diseases intelligence (2018), 44, 12 pages. DOI |
2020 |
Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Disparities in parental awareness of children's seasonal influenza vaccination recommendations and influencers of vaccination. PLoS One, 15(4), e0230425. DOI Scopus1 |
2020 |
Kaufman, J., Attwell, K., Tuckerman, J., O'Sullivan, J., Omer, S., Leask, J., . . . Danchin, M. (2020). Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot study. Vaccine, 38(24), 4024-4031. DOI |
2020 |
Tuckerman, J., Crawford, N. W., & Marshall, H. S. (2020). Seasonal influenza vaccination for children with special risk medical conditions: Does policy meet practice?. J Paediatr Child Health, 56(9), 1388-1395. DOI Scopus1 WoS1 |
2020 |
McMillan, M., Walters, L., Sullivan, T., Leong, L. E. X., Turra, M., Lawrence, A., . . . Marshall, H. S. (2020). Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. DOI |
2020 |
Parikh, S., Campbell, H., Bettinger, J., Harrison, L., Marshall, H., Martinon-Torres, F., . . . Ladhani, S. (2020). The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Journal of Infection, 81(4), 483-498. DOI Scopus5 WoS3 |
2020 |
McRae, J. E., Quinn, H. E., Saravanos, G. L., Carlson, S. J., Britton, P. N., Crawford, N. W., . . . Macartney, K. K. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 44. DOI Scopus1 |
2020 |
Top, K., Macartney, K., Bettinger, J., Tan, B., Blyth, C., Marshall, H., . . . McIntyre, P. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance, 25(25), 1-12. DOI Scopus1 WoS1 |
2019 |
MacIntyre, C., Shaw, P., Mackie, F., Boros, C., Marshall, H., Seale, H., . . . Stormon, M. (2019). Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 37(37), 5630-5636. DOI Scopus3 WoS3 Europe PMC2 |
2019 |
Tuckerman, J., Misan, S., Crawford, N. W., & Marshall, H. S. (2019). Influenza in Children With Special Risk Medical Conditions: A Systematic Review and Meta-analysis. The Pediatric infectious disease journal, 38(9), 912-919. DOI Scopus1 |
2019 |
Carlson, S., Scanlan, C., Marshall, H., Blyth, C., Macartney, K., & Leask, J. (2019). Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine, 37(40), 5994-6001. DOI Scopus3 WoS4 Europe PMC1 |
2019 |
Rahaman, M. R., Milazzo, A., Marshall, H., & Bi, P. (2019). Is a One Health Approach Utilized for Q Fever Control? A Comprehensive Literature Review.. International journal of environmental research and public health, 16(5), 22 pages. DOI Scopus4 WoS5 Europe PMC1 |
2019 |
Goh, A. E. N., Choi, E. H., Chokephaibulkit, K., Choudhury, J., Kuter, B., Lee, P. I., . . . Wolfson, L. J. (2019). Burden of varicella in the Asia-Pacific region: a systematic literature review. Expert Review of Vaccines, 18(5), 475-493. DOI Scopus3 WoS4 Europe PMC2 |
2019 |
Mohammed, H., McMillan, M., Roberts, C. T., & Marshall, H. S. (2019). A systematic review of interventions to improve uptake of pertussis vaccination in pregnancy.. PloS one, 14(3), 0214538. DOI Scopus10 WoS11 Europe PMC3 |
2019 |
Wang, B., Santoreneos, R., Giles, L., Haji Ali Afzali, H., & Marshall, H. (2019). Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine, 37(21), 2768-2782. DOI Scopus19 WoS19 Europe PMC2 |
2019 |
Marshall, H., McMillan, M., Koehler, A., Lawrence, A., MacLennan, J., Maiden, M., . . . Vadivelu, K. (2019). B part of it school leaver protocol: An observational repeat cross-sectional study to assess the impact of a meningococcal serogroup b (4cmenb) vaccine programme on carriage of neisseria meningitidis. BMJ Open, 9(5), 1-7. DOI Scopus3 WoS3 Europe PMC2 |
2019 |
Nolan, T., Booy, R., Marshall, H., Richmond, P., Nissen, M., Ziegler, J., . . . Van der Wielen, M. (2019). Immunogenicity and safety of a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine 6 years after MenC priming as toddlers. The Pediatric Infectious Disease Journal, 38(6), 643-650. DOI Scopus2 WoS2 |
2019 |
Marshall, H. S., & Amirthalingam, G. (2019). Protecting pregnant women and their newborn from life-threatening infections. Medical Journal of Australia, 210(10), 445-446. DOI |
2019 |
Marshall, H., Clarke, M., Heath, C., Quinn, H., Richmond, P., Crawford, N., . . . Macartney, K. (2019). Severe and complicated varicella and associated genotypes 10 years after introduction of a one-dose varicella vaccine program. Journal of Infectious Diseases, 219(3), 391-399. DOI Scopus4 WoS3 Europe PMC1 |
2019 |
McMillan, M., Walters, L., Mark, T., Lawrence, A., Leong, L., Sullivan, T., . . . Marshall, H. (2019). B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Human Vaccines and Immunotherapeutics, 15(4), 987-994. DOI Scopus6 WoS6 Europe PMC3 |
2019 |
Quinn, H., Gidding, H., Marshall, H., Booy, R., Elliott, E., Richmond, P., . . . Macartney, K. (2019). Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. Journal of Infection, 78(3), 220-225. DOI Scopus7 WoS7 Europe PMC3 |
2019 |
Tuckerman, J., Crawford, N. W., Lynch, J., & Marshall, H. S. (2019). Are children with special risk medical conditions receiving influenza vaccination? Validity of parental and provider report, and to a National Immunisation Register. Human Vaccines and Immunotherapeutics, 15(4), 951-958. DOI Scopus2 WoS2 Europe PMC1 |
2019 |
Nolan, T., Santolaya, M., de Looze, F., Marshall, H., Richmond, P., Henein, S., . . . O'Ryan, M. (2019). Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine. Vaccine, 37(9), 1209-1218. DOI Scopus11 WoS11 Europe PMC5 |
2019 |
McRae, J. E., Quinn, H. E., Saravanos, G. L., McMinn, A., Britton, P. N., Wood, N., . . . Macartney, K. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable diseases intelligence (2018), 43. DOI Scopus1 Europe PMC1 |
2019 |
Marshall, H. S., Baber, J., Richmond, P., Nissen, M., Shakib, S., Kreiswirth, B. N., . . . Anderson, A. S. (2019). S. aureus Colonization in Healthy Australian Adults Receiving an Investigational S. aureus 3-antigen Vaccine.. The Journal of infection, 79(6), 582-592. DOI |
2019 |
Wang, B., Hajiali Afzali, H., Giles, L., & Marshall, H. (2019). Lifetime costs of invasive meningococcal disease: a Markov model approach. Vaccine, 37(46), 6885-6893. DOI Scopus1 Europe PMC1 |
2019 |
Wooldridge, A. L., McMillan, M., Kaur, M., Giles, L. C., Marshall, H. S., & Gatford, K. L. (2019). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review. Journal of Allergy and Clinical Immunology, 144(6), 1703-1713. DOI Scopus1 WoS1 |
2019 |
Marshall, H., McMillan, M., Wang, B., Booy, R., Afzali, H., Buttery, J., . . . Barton, B. (2019). AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults.. BMJ Open, 9(12), e032583. DOI Scopus1 WoS1 |
2019 |
Oliver, J., Thielemans, E., McMinn, A., Baker, C., Britton, P. N., Clark, J. E., . . . Crawford, N. W. (2019). Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study. BMC Public Health, 19(1), 1750-1-1750-10. DOI Scopus2 WoS1 |
2019 |
Pearce, J., Peters, M. D. J., May, N., Marshall, H., Hein, C., & Grantham, H. (2019). Care of the patient with invasive meningococcal disease by emergency medical service clinicians: A scoping review protocol. Australasian Journal of Paramedicine, 16, 1-7. DOI Scopus1 |
2019 |
McHugh, L., Marshall, H. S., Perrett, K. P., Nolan, T., Wood, N., Lambert, S. B., . . . Andrews, R. M. (2019). The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum study. Clinical Infectious Diseases, 68(3), 402-408. DOI Scopus9 WoS9 Europe PMC5 |
2019 |
Butler, J., Gunnarsson, R., Traves, A., & Marshall, H. (2019). Severe respiratory syncytial virus infection in hospitalized children less than 3 years of age in a temperate and tropical climate. Pediatric Infectious Disease Journal, 38(1), 6-11. DOI |
2019 |
Blyth, C. C., Macartney, K. K., McRae, J., Clark, J. E., Marshall, H. S., Buttery, J., . . . Influenza Complications Alert Network (FluCAN) Collaboration. (2019). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2017: results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948. DOI Scopus15 WoS18 Europe PMC8 |
2018 |
Patel, C., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018). The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?. Eurosurveillance, 23(41), 30-40. DOI Scopus52 WoS37 Europe PMC10 |
2018 |
Wood, N., Nolan, T., & Marshall, H. (2018). Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial. Clinical Infectious Diseases, 172(11), 1045-1052. DOI Scopus15 WoS15 Europe PMC4 |
2018 |
Cyra, P., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., & Marshall, H. (2018). The impact of ten years of HPV vaccination in Australia: what additional disease burden could a 9-valent vaccine prevent?. Eurosurveillance. |
2018 |
Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis in mice leads to impaired antibody responses and enhanced T cell cytokine recall responses to vaccination. Cell Host and Microbe. |
2018 |
Lynn, M., Tumes, D., Choo, J., Sribnaia, A., Blake, S., Leong, L., . . . Lynn, D. (2018). Early-life antibiotic-driven dysbiosis leads to dysregulated vaccine immune responses in mice. Cell Host and Microbe, 23(5), 653-660. DOI Scopus38 WoS39 Europe PMC19 |
2018 |
Mohammed, H., Clarke, M., Koehler, A., Watson, M., & Marshall, H. (2018). Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia. PLoS ONE, 13(6), e0197867-1-e0197867-14. DOI Scopus25 WoS24 Europe PMC11 |
2018 |
Wang, B., Santoreneos, R., Afzali, H., Giles, L., & Marshall, H. (2018). Costs of invasive meningococcal disease: a global systematic review. PharmacoEconomics, 36(10), 1201-1222. DOI Scopus7 WoS6 Europe PMC4 |
2018 |
Marshall, H. S., McMillan, M., Koehler, A., Lawrence, A., Maclennan, J. M., Maiden, M. C. J., . . . Vadivelu, K. (2018). B Part of It protocol: A cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open, 8(7), 9 pages. DOI Scopus16 WoS12 Europe PMC10 |
2018 |
Bedford, H., Attwell, K., Danchin, M., Marshall, H., Corben, P., & Leask, J. (2018). Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology. Vaccine, 36(44), 6556-6558. DOI Scopus48 WoS43 Europe PMC17 |
2018 |
Marshall, H. S., Vesikari, T., Richmond, P. C., Szenborn, L., Beeslaar, J., Maguire, J. D., . . . Investigators, B. 1. 9. 7. 1. 0. 3. 5. S. (2018). A Phase 2 Study of the Immunogenicity, Safety, and Tolerability of MenB-FHbp, a Bivalent Meningococcal B Vaccine, in Healthy Toddlers. |
2018 |
Marshall, H., & Plotkin, S. (2018). The changing epidemiology of mumps in a high vaccination era. The Lancet Infectious Diseases, 19(2), 118-119. DOI Scopus4 Europe PMC2 |
2018 |
Cutland, C., Nolan, T., Halperin, S., Kurugol, Z., Ahmed, K., Perrett, K., . . . Van Der Wielen, M. (2018). Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study. Vaccine, 36(14), 1908-1916. DOI Scopus8 WoS8 Europe PMC3 |
2018 |
Tuckerman, J., Misan, S., Salih, S., Joseph Xavier, B., Crawford, N., Lynch, J., & Marshall, H. (2018). Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions. Vaccine, 36(52), 8138-8147. DOI Scopus7 WoS7 Europe PMC3 |
2017 |
Fell, D., Azziz-Baumgartner, E., Baker, M., Batra, M., Beauté, J., Beutels, P., . . . Ortiz, J. (2017). Influenza epidemiology and immunization during pregnancy: final report of a World Health Organization working group. Vaccine, 35(43), 5738-5750. DOI Scopus45 WoS41 Europe PMC28 |
2017 |
McMillan, M., Clarke, M., Parrella, A., Fell, D., Amirthalingam, G., & Marshall, H. (2017). Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy a systematic review. Obstetrics and Gynecology, 129(3), 560-573. DOI Scopus48 WoS41 Europe PMC23 |
2017 |
Marshall, H., Richmond, P., Beeslaar, J., Jiang, Q., Jansen, K., Garcés-Sánchez, M., . . . Perez, J. (2017). Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 17(1), 58-67. DOI Scopus24 WoS22 Europe PMC11 |
2017 |
McHugh, L., Andrews, R. M., Lambert, S. B., Viney, K. A., Wood, N., Perrett, K. P., . . . O'Grady, K. A. F. (2017). Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study. Vaccine, 35(10), 1403-1409. DOI Scopus21 WoS19 Europe PMC12 |
2017 |
Forster, A., Mahendran, K., Davies, C., Stoney, T., Marshall, H., McGeechan, K., . . . Skinner, S. (2017). Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health, 147, 77-83. DOI Scopus9 WoS10 Europe PMC3 |
2017 |
Davies, C., Skinner, S., Stoney, T., Marshall, H., Collins, J., Jones, J., . . . Zimet, G. (2017). 'Is it like one of those infectious kind of things?' The importance of educating young people about HPV and HPV vaccination at school. Sex Education, 17(3), 256-275. DOI Scopus8 WoS7 |
2017 |
Britton, P., Blyth, C., Macartney, K., Dale, R., Li-Kim-Moy, J., Khandaker, G., . . . Jones, C. (2017). The spectrum and burden of influenza-associated neurological disease in children: combined encephalitis and influenza sentinel site surveillance from Australia 2013-2015. Clinical Infectious Diseases, 65(4), 653-660. DOI Scopus33 WoS34 |
2017 |
Katz, M., Gessner, B., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. (2017). Incidence of influenza virus infection among pregnant women: A systematic review. BMC Pregnancy and Childbirth, 17(1), 12 pages. DOI Scopus19 WoS16 Europe PMC13 |
2017 |
Costa-Pinto, J., Willaby, H., Leask, J., Wood, N., Marshall, H., & Danchin, M. (2017). Vaccine discussions with parents: The experience of Australian paediatricians. Journal of Paediatrics and Child Health, 53(9), 855-861. DOI Scopus4 WoS4 Europe PMC2 |
2017 |
Katz, M. A., Gessner, B. D., Johnson, J., Skidmore, B., Knight, M., Bhat, N., . . . Fell, D. B. (2017). Erratum: Incidence of influenza virus infection among pregnant women: A systematic review [BMC Pregnancy and Childbirth., 17, 1, (2017) (155)] DOI:10.1186/s12884-017-1333-5. BMC Pregnancy and Childbirth, 17(1), 1 page. DOI Scopus2 WoS1 |
2017 |
Britton, P., Dale, R., Blyth, C., Macartney, K., Crawford, N., Marshall, H., . . . Jones, C. (2017). Influenza-associated encephalitis/encephalopathy identified by the Australian Childhood Encephalitis study 2013-2015. Pediatric Infectious Disease Journal, 36(11), 1021-1026. DOI Scopus21 WoS18 Europe PMC8 |
2017 |
Wang, B., Chen, G., Ratcliffe, J., Afzali, H., Giles, L., & Marshall, H. (2017). Adolescent values for immunisation programs in Australia: a discrete choice experiment. PLoS ONE, 12(7), e0181073-1-e0181073-14. DOI Scopus7 WoS7 Europe PMC5 |
2017 |
Danchin, M., Costa-Pinto, J., Atwell, K., Willaby, H., Wiley, K., Hoq, M., . . . Marshall, H. (2017). Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine, 36(44), 6473-6479. DOI Scopus49 WoS43 Europe PMC14 |
2017 |
Britton, P. N., Blyth, C. C., Macartney, K., Dale, R. C., Li-Kim-Moy, J., Khandaker, G., . . . Australian Childhood Encephalitis (ACE) Study Investigators, Influenza Complications Alert Network (FluCAN) Investigators, and Paediatric Active Enhanced Disease Surveillance (PAEDS) Network. (2017). The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance From Australia, 2013-2015.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 65(4), 653-660. DOI Europe PMC18 |
2017 |
DeSilva, M., Munoz, F. M., Sell, E., Marshall, H., Tse Kawai, A., Kachikis, A., . . . Bardají, A. (2017). Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation. Vaccine, 35(48), 6472-6482. DOI Scopus17 WoS20 Europe PMC12 |
2017 |
Sweet, L., Keech, C., Klein, N., Marshall, H., Tagbo, B., Quine, D., . . . Muñoz, F. (2017). Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine, 35(48), 6506-6517. DOI Scopus5 WoS6 Europe PMC3 |
2017 |
Tooher, R., collins, J., Braunack-Mayer, A., burgess, T., Skinner, S., O'keefe, M., . . . Marshall, H. (2017). Intersectoral collaboration to implement school-based health programmes: Australian perspectives. Health Promotion International, 32(2), 312-321. DOI Scopus11 WoS11 Europe PMC3 |
2017 |
Fell, D., Savitz, D., Kramer, M., Gessner, B., Katz, M., Knight, M., . . . Ortiz, J. (2017). Maternal influenza and birth outcomes: systematic review of comparative studies. BJOG: An International Journal of Obstetrics and Gynaecology, 124(1), 48-59. DOI Scopus59 WoS56 Europe PMC28 |
2016 |
Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2016). Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine, 34(34), 3967-3971. DOI Scopus14 WoS15 Europe PMC11 |
2016 |
Lakhan, N., Clarke, M., Mathew, S., & Marshall, H. (2016). Retrospective review of factors associated with severe hospitalised community-acquired influenza in a tertiary paediatric hospital in South Australia. Influenza and other Respiratory Viruses, 10(6), 479-485. DOI Scopus4 WoS4 Europe PMC2 |
2016 |
MacIntyre, C., Shaw, P., Mackie, F., Boros, C., Marshall, H., Barnes, M., . . . Stormon, M. (2016). Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine, 34(36), 4343-4350. DOI Scopus14 WoS12 Europe PMC3 |
2016 |
DeSilva, M., Munoz, F. M., Mcmillan, M., Kawai, A. T., Marshall, H., Macartney, K. K., . . . Kharbanda, E. O. (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026. DOI Scopus30 WoS24 Europe PMC8 |
2016 |
Marshall, H., Nissen, M., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2016). Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study. Journal of Infection, 73(5), 437-454. DOI Scopus9 WoS9 Europe PMC6 |
2016 |
Mcbride, W., Abhayaratna, W., Barr, I., Booy, R., Carapetis, J., Carson, S., . . . Greenberg, M. (2016). Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial. Vaccine, 34(41), 4991-4997. DOI Scopus5 WoS5 Europe PMC5 |
2016 |
Cooper, S., Davies, C., McBride, K., Blades, J., Stoney, T., Marshall, H., & Skinner, S. (2016). Development of a human papillomavirus vaccination intervention for Australian adolescents. Health Education Journal, 75(5), 610-620. DOI Scopus7 WoS6 |
2016 |
Wang, B., Giles, L., Afzali, H., Clarke, M., Ratcliffe, J., Chen, G., & Marshall, H. (2016). Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults. Vaccine, 34(46), 5595-5603. DOI Scopus4 WoS3 Europe PMC2 |
2016 |
Safarchi, A., Octavia, S., Wu, S., Kaur, S., Sintchenko, V., Gilbert, G., . . . Lan, R. (2016). Genomic dissection of Australian Bordetella pertussis isolates from the 2008-2012 epidemic. Journal of Infection, 72(4), 468-477. DOI Scopus19 WoS20 Europe PMC16 |
2016 |
Tuckerman, J., Thomas, N., & Marshall, H. (2016). Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation. Vaccine, 34(14), 1726-1732. DOI Scopus6 WoS4 Europe PMC4 |
2016 |
Marshall, H., McMillan, M., Andrews, R., Macartney, K., & Edwards, K. (2016). Vaccines in pregnancy: the dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856. DOI Scopus27 WoS27 Europe PMC15 |
2016 |
Parrella, A., Braunack-Mayer, A., Collins, J., Clarke, M., Tooher, R., Ratcliffe, J., & Marshall, H. (2016). Prioritizing government funding of adolescent vaccinations: recommendations from young people on a citizens' jury. Vaccine, 34(31), 3592-3597. DOI Scopus2 WoS2 Europe PMC2 |
2016 |
Clarke, M., McIntyre, P., Blyth, C., Wood, N., Octavia, S., Sintchenko, V., . . . Marshall, H. (2016). The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. Journal of Infection, 72(2), 171-178. DOI Scopus20 WoS21 Europe PMC17 |
2016 |
Burgess, T., Braunack-Mayer, A., Tooher, R., Collins, J., O'Keefe, M., Skinner, R., . . . Marshall, H. (2016). Optimizing intersectoral collaboration between health and education: the Health Bridges study. Journal of Public Health, 38(4), e430-e437. DOI Scopus6 WoS2 |
2016 |
Marshall, H., Chen, G., Clarke, M., & Ratcliffe, J. (2016). Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: a Discrete Choice Experiment. Vaccine, 34(5), 671-677. DOI Scopus21 WoS20 Europe PMC18 |
2016 |
Wooldridge, A., McMillan, M., Marshall, H., & Gatford, K. (2016). Relationship between birth weight or fetal growth rate and postnatal allergy: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports, 14(11), 11-20. DOI Scopus4 |
2016 |
Marshall, H., Wang, B., Wesselingh, S., Snape, M., & Pollard, A. J. (2016). Control of invasive meningococcal disease: Is it achievable?. International Journal of Evidence-Based Healthcare, 14(1), 3-12. DOI Scopus7 WoS7 Europe PMC3 |
2016 |
Tuckerman, J., Shrestha, L., Collins, J., & Marshall, H. (2016). Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia. Human Vaccines and Immunotherapeutics, 12(7), 1749-1756. DOI Scopus4 WoS3 Europe PMC1 |
2016 |
Burgess, T., Braunack-Mayer, A., Tooher, R., Collins, J., O'Keefe, M., Skinner, R., . . . Marshall, H. (2016). Optimizing intersectoral collaboration between health and education: the Health Bridges study.. Journal of public health (Oxford, England), 38(4), e430-e437. DOI Europe PMC3 |
2015 |
La Vincente, S., Mielnik, D., Jenkins, K., Bingwor, F., Volavola, L., Marshall, H., . . . Mulholland, E. (2015). Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents. BMC Public Health, 15(1), 1257-1-1257-11. DOI Scopus7 WoS5 Europe PMC6 |
2015 |
Pearce, A., Marshall, H., Bedford, H., & Lynch, J. (2015). Barriers to childhood immunisation: findings from the Longitudinal Study of Australian Children. Vaccine, 33(29), 3377-3383. DOI Scopus48 WoS42 Europe PMC21 |
2015 |
Braunack-Mayer, A., Skinner, S., Collins, J., Tooher, R., Proeve, C., O'Keefe, M., . . . Marshall, H. (2015). Ethical challenges in school-based immunization programs for adolescents: a qualitative study. American Journal of Public Health, 105(7), 1399-1403. DOI Scopus11 WoS10 Europe PMC9 |
2015 |
Tuckerman, J., Collins, J., & Marshall, H. (2015). Factors affecting uptake of recommended immunizations among health care workers in South Australia. Human Vaccines and Immunotherapeutics, 11(3), 704-712. DOI Scopus21 WoS19 Europe PMC9 |
2015 |
Nissen, M., Marshall, H., Richmond, P., Shakib, S., Jiang, Q., Cooper, D., . . . Girgenti, D. (2015). A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. Vaccine, 33(15), 1846-1854. DOI Scopus46 WoS47 Europe PMC30 |
2015 |
McMillan, M., Porritt, K., Kralik, D., Costi, L., & Marshall, H. (2015). Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine, 33(18), 2108-2117. DOI Scopus87 WoS83 Europe PMC61 |
2015 |
Wong, C., Thomas, N., Clarke, M., Boros, C., Tuckerman, J., & Marshall, H. (2015). Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunzations. Human Vaccines and Immunotherapeutics, 11(5), 1165-1172. DOI Scopus26 WoS25 Europe PMC11 |
2015 |
Marshall, H., Richmond, P., Nissen, M., Lambert, S., Booy, R., Reynolds, G., . . . Scully, I. (2015). Group A streptococcal carriage and seroepidemiology in children up to 10 years of age in Australia. Pediatric Infectious Disease Journal, 34(8), 831-838. DOI Scopus7 WoS7 Europe PMC3 |
2015 |
Safarchi, A., Octavia, S., Luu, L., Tay, C., Sintchenko, V., Wood, N., . . . Lan, R. (2015). Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine, 33(46), 6277-6281. DOI Scopus45 WoS48 Europe PMC33 |
2015 |
Clarke, M., Thomas, N., Giles, L., & Marshall, H. (2015). Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults. Vaccine, 33(51), 7337-7343. DOI Scopus4 WoS4 Europe PMC2 |
2015 |
Perrett, K., McVernon, J., Richmond, P., Marshall, H., Nissen, M., August, A., . . . Nolan, T. (2015). Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study. Vaccine, 33(39), 5217-5224. DOI Scopus24 WoS25 Europe PMC17 |
2015 |
Skinner, S., Davies, C., Cooper, S., Stoney, T., Marshall, H., Jones, J., . . . McGeechan, K. (2015). HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents. BMC Public Health, 15(1), 896-1-896-9. DOI Scopus11 WoS9 Europe PMC4 |
2015 |
Booy, R., Nolan, T., Reynolds, G., Richmond, P., Nissen, M., Marshall, H., . . . Miller, J. (2015). Five-year antibody persistence and safety after a single dose of combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in Haemophilus influenzae Type B-primed toddlers. Pediatric Infectious Disease Journal, 34(12), 1379-1384. DOI Scopus4 WoS3 Europe PMC2 |
2015 |
Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., . . . Wood, N. (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. DOI Scopus17 WoS17 Europe PMC10 |
2015 |
Marshall, H., Clarke, M., Rasiah, K., Richmond, P., Buttery, J., Reynolds, G., . . . Mcintyre, P. (2015). Predictors of disease severity in children hospitalized for pertussis during an epidemic. Pediatric Infectious Disease Journal, 34(4), 339-345. DOI Scopus34 WoS35 Europe PMC18 |
2014 |
Nolan, T., Izurieta, P., Lee, B., Chan, P., Marshall, H., Booy, R., . . . Vaughn, D. (2014). Heterologous prime-boost vaccination using an ASO3B-adjuvanted influenza A(H5N1) vaccine in infants and children <3 years of age. Journal of Infectious Diseases, 210(11), 1800-1810. DOI Scopus11 WoS11 Europe PMC8 |
2014 |
McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2014). Influenza vaccination during pregnancy: A systematic review of effectiveness and safety. JBI Database of Systematic Reviews and Implementation Reports, 12(6), 281-381. DOI Scopus4 |
2014 |
Wang, B., Clarke, M., Thomas, N., Howell, S., Afzali, H., & Marshall, H. (2014). The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children. Pediatric Infectious Disease Journal, 33(3), 316-318. DOI Scopus15 WoS13 Europe PMC8 |
2014 |
O'Grady, K., McHugh, L., Nolan, T., Richmond, P., Wood, N., Marshall, H., . . . Andrews, R. (2014). FluMum: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in revention of influenza in early infancy. BMJ Open, 4(6), e005676-1-e005676-6. DOI Scopus10 WoS12 Europe PMC8 |
2014 |
Taylor, K., Stocks, N., & Marshall, H. (2014). The missing link: family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine, 32(33), 4214-4219. DOI Scopus5 WoS5 Europe PMC4 |
2014 |
Khandaker, G., Zurynski, Y., Ridley, G., Buttery, J., Marshall, H., Richmond, P., . . . Elliott, E. (2014). Clinical epidemiology and predictors of outcome in children hospitalised with influenza A(H1N1)pdm09 in 2009: a prospective national study. Influenza and Other Respiratory Viruses, 8(6), 636-645. DOI Scopus20 WoS11 Europe PMC13 |
2014 |
Collins, J., Alona, I., Tooher, R., & Marshall, H. (2014). Increased awareness and health care provider endorsement is required to encourage pregnant women to be vaccinated. Human Vaccines and Immunotherapeutics, 10(10), 2922-2929. DOI Scopus26 WoS21 Europe PMC16 |
2014 |
Wood, N., Marshall, H., White, O., Holt, P., & McIntyre, P. (2014). Antibody and cell-mediated immunity to pertussis 4 years after monovalent acellular pertussis vaccine at birth. Pediatric Infectious Disease Journal, 33(5), 511-517. DOI Scopus10 WoS10 Europe PMC6 |
2014 |
Wang, B., Haji Ali Afzali, H., & Marshall, H. (2014). The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine, 32(37), 4791-4798. DOI Scopus21 WoS16 Europe PMC12 |
2014 |
Webb, H., Street, J., & Marshall, H. (2014). Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations. Human Vaccines & Immunotherapeutics, 10(4), 1114-1121. DOI Scopus28 WoS24 Europe PMC18 |
2014 |
Lam, C., & Marshall, H. (2014). Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633. DOI Scopus107 WoS116 Europe PMC79 |
2014 |
Marshall, H., Proeve, C., Collins, J., Tooher, R., O'Keefe, M., Burgess, T., . . . Braunack-Mayer, A. (2014). Eliciting youth and adult recommendations through citizens' juries to improve school based adolescent immunisation programs. Vaccine, 32(21), 2434-2440. DOI Scopus16 WoS15 Europe PMC11 |
2014 |
Parrella, A., Gold, M., Braunack-Mayer, A., Baghurst, P., & Marshall, H. (2014). Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Human Vaccines & Immunotherapeutics, 10(3), 747-754. DOI Scopus9 WoS9 Europe PMC9 |
2014 |
Wang, B., Clarke, M., Hajiali Afzali, H., & Marshall, H. (2014). Community, parental and adolescent awareness and knowledge of meningococcal disease. Vaccine, 32(18), 2042-2049. DOI Scopus14 WoS12 Europe PMC10 |
2014 |
Marshall, H., Clarke, M., & Sullivan, T. (2014). Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine, 32(3), 338-344. DOI Scopus26 WoS24 Europe PMC16 |
2014 |
Tuckerman, J., Marshall, H., Snape, M., Collins, J., Straube, S., & Chambers, A. G. (2014). Interventions for increasing the uptake of immunisation in healthcare workers. Cochrane Database of Systematic Reviews, 2014(11). DOI |
2013 |
Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., . . . Liu, S. (2013). International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. DOI Scopus63 WoS60 Europe PMC42 |
2013 |
Tooher, R., Collins, J., Street, J., Braunack-Mayer, A., & Marshall, H. (2013). Community knowledge, behaviours and attitudes about the 2009 H1N1 influenza pandemic: a systematic review. Influenza and Other Respiratory Viruses, 7(6), 1316-1327. DOI Scopus23 WoS22 Europe PMC13 |
2013 |
Parrella, A., Braunack-Mayer, A., Gold, M., Marshall, H., & Baghurst, P. (2013). Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Services Research, 13(313), 1-12. DOI Scopus19 WoS18 Europe PMC10 |
2013 |
Lambert, S., Chuk, L., Nissen, M., Nolan, T., McVernon, J., Booy, R., . . . Lai, M. (2013). Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza and Other Respiratory Viruses, 7(5), 676-685. DOI Scopus15 WoS14 Europe PMC5 |
2013 |
Marshall, H., Clarke, M., Evans, S., Piotto, L., & Gent, R. (2013). Randomized trial using ultrasound to assess intramuscular vaccination at a 60 degrees or 90 degrees needle angle. Vaccine, 31(23), 2647-2652. DOI Scopus4 WoS4 Europe PMC4 |
2013 |
Marshall, H., Collins, J., Sullivan, T., Tooher, R., O'Keefe, M., Skinner, S., . . . Braunack-Mayer, A. (2013). Parental and societal support for adolescent immunization through school based immunization programs. Vaccine, 31(30), 3059-3064. DOI Scopus11 WoS10 Europe PMC6 |
2013 |
Marshall, H., McIntyre, P., Richmond, P., Buttery, J., Royle, J., Gold, M., . . . Booy, R. (2013). Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal, 32(5), 530-537. DOI Scopus31 WoS27 Europe PMC20 |
2013 |
Braunack-Mayer, A., Tooher, R., Collins, J., Street, J., & Marshall, H. (2013). Understanding the school community's response to school closures during the H1N1 2009 influenza pandemic. BMC Public Health, 13(1), 1-15. DOI Scopus45 WoS33 Europe PMC20 |
2013 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., & Baghurst, P. (2013). Parental perspectives of vaccine safety and experience of adverse events following immunisation. Vaccine, 31(16), 2067-2074. DOI Scopus27 WoS26 Europe PMC20 |
2013 |
Nissen, M., Marshall, H., Richmond, P., Jiang, Q., Harris, S., Jones, T., . . . Perez, J. (2013). A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. Pediatric Infectious Disease Journal, 32(4), 364-371. DOI Scopus47 WoS44 Europe PMC34 |
2013 |
Marshall, H., Richmond, P., Nissen, M., Wouters, A., Baber, J., Jiang, Q., . . . Perez, J. (2013). A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine, 31(12), 1569-1575. DOI Scopus58 WoS54 Europe PMC41 |
2013 |
Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Miller, J. (2013). Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine in hib-primed toddlers. Pediatric Infectious Disease Journal, 32(2), 169-174. DOI Scopus7 WoS7 Europe PMC4 |
2013 |
Clarke, M., Rasiah, K., Copland, J., Watson, M., Koehler, A., Dowling, K., & Marshall, H. (2013). The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiology and Infection, 141(3), 463-471. DOI Scopus11 WoS12 Europe PMC8 |
2012 |
Bryant, K., McVernon, J., Marchant, C., Nolan, T., Marshall, G., Richmond, P., . . . Miller, J. (2012). Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Human Vaccines & Immunotherapeutics, 8(8), 1036-1041. DOI Scopus7 WoS6 Europe PMC6 |
2012 |
Richmond, P., Marshall, H., Nissen, M., Jiang, Q., Jansen, K., Garces-Sanchez, M., . . . Perez, J. (2012). Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases, 12(8), 597-607. DOI Scopus109 WoS94 Europe PMC81 |
2012 |
Parrella, A., Gold, M., Marshall, H., Braunack-Mayer, A., Watson, M., & Baghurst, P. (2012). Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010. Human Vaccines & Immunotherapeutics, 8(5), 662-667. DOI Scopus14 WoS12 Europe PMC9 |
2012 |
Kessels, S., Marshall, H., Watson, M., Braunack-Mayer, A., Reuzel, R., & Tooher, R. (2012). Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine, 30(24), 3546-3556. DOI Scopus277 WoS263 Europe PMC200 |
2012 |
Marshall, H., Tooher, R., Collins, J., Mensah, F., Braunack-Mayer, A., Street, J., & Ryan, P. (2012). Awareness, anxiety, compliance: Community perceptions and response to the threat and reality of an influenza pandemic. American Journal of Infection Control, 40(3), 270-272. DOI Scopus9 WoS7 Europe PMC7 |
2012 |
McVernon, J., Nolan, T., Richmond, P., Reynolds, G., Nissen, M., Lambert, S., . . . Rehm, C. (2012). A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers. Pediatric Infectious Disease Journal, 31(1), E15-E23. DOI Scopus13 WoS11 Europe PMC7 |
2012 |
Seale, H., Trung, L., Mackie, F., Kennedy, S., Boros, C., Marshall, H., . . . MacIntyre, C. (2012). A qualitative study investigating knowledge and attitudes regarding human papillomavirus (HPV) and the HPV vaccine among parents of immunosuppressed children. Vaccine, 30(49), 7027-7031. DOI Scopus7 WoS6 Europe PMC5 |
2012 |
Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., . . . Booy, R. (2012). Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481. DOI Scopus43 WoS37 Europe PMC30 |
2012 |
Marshall, H., Richmond, P., Nissen, M., Jiang, Q., Anderson, A., Jansen, K., . . . Perez, J. (2012). Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: A phase 1 randomized-controlled clinical trial. Pediatric Infectious Disease Journal, 31(10), 1061-1068. DOI Scopus56 WoS51 Europe PMC41 |
2012 |
Khandaker, G., Rashid, H., Zurynski, Y., Richmond, P., Buttery, J., Marshall, H., . . . Booy, R. (2012). Nosocomial vs community-acquired pandemic influenza A (H1N1) 2009: a nested case-control study. Journal of Hospital Infection, 82(2), 94-100. DOI Scopus4 WoS4 Europe PMC3 |
2012 |
Richmond, P., Nissen, M., Marshall, H., Lambert, S., Roberton, D., Gruber, W., . . . Arora, A. (2012). A bivalent Neisserie meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine, 30(43), 6163-6174. DOI Scopus44 WoS45 Europe PMC39 |
2012 |
Clarke, M., & Marshall, H. (2012). Rotavirus vaccination for prevention of serious acute gastroenteritis and the importance of postlicensure safety monitoring. Journal of Infectious Diseases, 206(1), 3-5. DOI Scopus1 WoS1 |
2012 |
McMillan, M., Kralik, D., Porritt, K., & Marshall, H. (2012). Influenza vaccination during pregnancy: A systematic review of effectiveness and adverse effects. JBI Database of Systematic Reviews and Implementation Reports, 10(56 Suppl), S216-S226. DOI Scopus1 |
2011 |
Clarke, M., Davidson, G., Gold, M., & Marshall, H. (2011). Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine, 29(29-30), 4663-4667. DOI Scopus38 WoS39 Europe PMC25 |
2011 |
Quinn, P., Gold, M., Royle, J., Buttery, J., Richmond, P., McIntyre, P., . . . Marshall, H. (2011). Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old. Vaccine, 29(25), 4230-4237. DOI Scopus14 WoS16 Europe PMC9 |
2011 |
Khandaker, G., Marshall, H., Peadon, E., Zurynski, Y., Burgner, D., Buttery, J., . . . Booy, R. (2011). Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood, 96(5), 453-456. DOI Scopus29 WoS27 Europe PMC18 |
2011 |
Booy, R., Richmond, P., Nolan, T., McVernon, J., Marshall, H., Nissen, M., . . . Boutriau, D. (2011). Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age. Pediatric Infectious Disease Journal, 30(4), 340-342. DOI Scopus10 WoS9 Europe PMC7 |
2011 |
Nolan, T., Richmond, P., Marshall, H., McVernon, J., Alexander, K., Mesaros, N., . . . Boutriau, D. (2011). Immunogenicity and safety of an investigational combined haemophilus influenzae Type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatric Infectious Disease Journal, 30(3), 190-196. DOI Scopus25 WoS23 Europe PMC20 |
2011 |
Buttery, J. P., Danchin, M. H., Lee, K. J., Carlin, J. B., McIntyre, P. B., Elliott, E. J., . . . Bines, J. E. (2011). Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia. VACCINE, 29(16), 3061-3066. DOI WoS193 Europe PMC133 |
2010 |
Medina, D. M. R., Valencia, A., de Velasquez, A., Huang, L. -M., Prymula, R., Garcia-Sicilia, J., . . . Dubin, G. (2010). Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls. JOURNAL OF ADOLESCENT HEALTH, 46(5), 414-421. DOI WoS39 Europe PMC26 |
2010 |
Carbonell-Estrany, X., Simoes, E. A. F., Dagan, R., Hall, C. B., Harris, B., Hultquist, M., . . . Losonsky, G. A. (2010). Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. PEDIATRICS, 125(1), E35-E51. DOI WoS122 Europe PMC87 |
2010 |
White, O., Rowe, J., Richmond, P., Marshall, H., McIntyre, P., Wood, N., & Holt, P. (2010). Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine, 28(14), 2648-2652. DOI Scopus36 WoS35 Europe PMC31 |
2010 |
Marshall, H., Nolan, T., Diez-Domingo, J., Rombo, L., Sokal, E., Mares, J., . . . Jacquet, J. (2010). Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine, 28(27), 4411-4415. DOI Scopus10 WoS10 Europe PMC6 |
2010 |
Wood, N., McIntyre, P., Marshall, H., & Roberton, D. (2010). Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatric Infectious Disease Journal, 29(3), 209-215. DOI Scopus86 WoS76 Europe PMC54 |
2010 |
Nolan, T., McVernon, J., Skeljo, M., Richmond, P., Wadia, U., Lambert, S., . . . Greenberg, M. (2010). Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. Jama-journal of the American Medical Association, 303(1), 37-46. DOI Scopus170 WoS155 Europe PMC114 |
2010 |
Marshall, H., McIntyre, P., Roberton, D., Dinan, L., & Hardt, K. (2010). Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. International Journal of Infectious Diseases, 14(1), E41-E49. DOI Scopus3 WoS3 Europe PMC3 |
2009 |
Marshall, H., Ryan, P., Roberton, D., & Beilby, J. (2009). Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine. Journal of Paediatrics and Child Health, 45(5), 297-303. DOI Scopus15 WoS15 Europe PMC9 |
2009 |
Gibson, R., Barclay, D., Marshall, H., Moulin, J., Maire, J., & Makrides, M. (2009). Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial. British Journal of Nutrition, 101(11), 1706-1713. DOI Scopus33 WoS34 Europe PMC22 |
2009 |
Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2009). Pandemic influenza and community preparedness. American Journal of Public Health, 99(SUPPL. 2), S365-S371. DOI Scopus30 WoS27 Europe PMC16 |
2009 |
de Benedictis, F. M., Franceschini, F., Hill, D., Naspitz, C., Simons, F. E. R., Wahn, U., . . . Vogel, M. (2009). The allergic sensitization in infants with atopic eczema from different countries. Allergy: European Journal of Allergy and Clinical Immunology, 64(2), 295-303. DOI Scopus84 Europe PMC49 |
2008 |
Marshall, H., Ryan, P., Roberton, D., Street, J., & Watson, M. (2008). Pandemic Influenza Preparedness: is the Community Really Prepared?. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 12, E439. DOI |
2008 |
Grüber, C., Warner, J., Hill, D., Bauchau, V., Warner, J. O., Naspitz, C. K., . . . Abeck, D. (2008). Early atopic disease and early childhood immunization - Is there a link?. Allergy: European Journal of Allergy and Clinical Immunology, 63(11), 1464-1472. DOI Scopus39 WoS28 Europe PMC18 |
2008 |
Hill, D. J., Hosking, C. S., de Benedictis, F. M., Oranje, A. P., Diepgen, T. L., Bauchau, V., & EPAAC Study Group. (2008). Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clinical & Experimental Allergy, 38(1), 161-168. DOI Scopus152 WoS134 Europe PMC82 |
2008 |
Nolan, T., Bernstein, D., Block, S., Hilty, M., Keyserling, H., Marchant, C., . . . Mendelman, P. (2008). Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with Measles-Mumps-Rubella and varicella vaccines to infants 12 to 15 months of age. Pediatrics, 121(3), 508-516. DOI Scopus34 WoS22 Europe PMC21 |
2008 |
Marshall, H. S., & Isaacs, D. (2008). "I want the one for older women" - Extending the human papillomavirus vaccine population base. Medical Journal of Australia, 189(9), 527. DOI |
2007 |
Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., Streeton, C., . . . Boutriau, D. (2007). A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine, 25(51), 8487-8499. DOI Scopus47 WoS44 Europe PMC36 |
2007 |
Nolan, T., Lambert, S., Roberton, D., Marshall, H., Richmond, P., & Streeton, C. (2007). DTPa-HBV-IPV vaccine for primary vaccination of infants. Journal of Paediatrics and Child Health, 43(9), 587-592. DOI Scopus8 WoS7 Europe PMC4 |
2007 |
Marshall, H., Ryan, P., Roberton, D., & Baghurst, P. (2007). A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Australian and New Zealand Journal of Public Health, 31(3), 235-242. DOI Scopus85 WoS84 Europe PMC55 |
2006 |
Peadon, E., Burgner, D., Nissen, M., Buttery, J., Zurynski, Y., Elliott, E., . . . Booy, R. (2006). Case for varicella surveillance in Australia. Journal of Paediatrics and Child Health, 42(11), 663-664. DOI Scopus7 WoS1 Europe PMC5 |
2006 |
Hofman, T., Cranswick, N., Kuna, P., Boznanski, A., Latos, T., Gold, M., . . . Szalai, Z. (2006). Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children. Archives of Disease in Childhood, 91(11), 905-910. DOI Scopus26 WoS23 Europe PMC15 |
2006 |
Marshall, H., Gold, M., Gent, R., Quinn, P., Piotto, L., Clarke, M., & Roberton, D. (2006). Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children. Pediatrics, 118(4), 1501-1509. DOI Scopus19 WoS18 Europe PMC13 |
2006 |
Marshall, H., Nolan, T., Roberton, D., Richmond, P., Lambert, S., Jacquet, J., & Schuerman, L. (2006). A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years. Vaccine, 24(35-36), 6120-6128. DOI Scopus18 WoS13 Europe PMC9 |
2006 |
Jacquet, J., Begue, P., Grimprel, E., Reinert, P., Sandbu, S., Silfverdal, S., . . . Schuerman, L. (2006). Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: A review. Vaccine, 24(13), 2440-2448. DOI Scopus23 WoS19 Europe PMC17 |
2005 |
Marshall, H., Ryan, P., & Roberton, D. (2005). Uptake of varicella vaccine - A cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine, 23(46-47), 5389-5397. DOI Scopus30 WoS31 Europe PMC20 |
2005 |
Roberton, D., Marshall, H., Nolan, T., Sokal, E., Diez-Domingo, J., Flodmark, C., . . . Stoffel, M. (2005). Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine, 23(43), 5099-5105. DOI Scopus11 WoS9 Europe PMC9 |
2004 |
Isaacs, D., Kilham, H., & Marshall, H. (2004). Should routine childhood immunizations be compulsory?. Journal of Paediatrics and Child Health, 40(7), 392-396. DOI Scopus17 WoS17 Europe PMC11 |
2004 |
Roberton, D., Marshall, H., Dinan, L., Boros, C., & Gold, M. (2004). Developmental immunology and vaccines: immune responses to vaccines in premature infants. Expert Review of Vaccines, 3(4), 343-347. DOI Scopus7 Europe PMC3 |
2004 |
Belshe, R., Newman, F., Anderson, E., Wright, P., Karron, R., Tollefson, S., . . . Tsai, T. (2004). Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. Journal of Infectious Diseases, 190(12), 2096-2103. DOI Scopus60 WoS47 Europe PMC35 |
2004 |
Belshe, R., Newman, F., Tsai, T., Karron, R., Reisinger, K., Roberton, D., . . . Anderson, E. (2004). Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old. Journal of Infectious Diseases, 189(3), 462-470. DOI Scopus45 WoS37 Europe PMC27 |